scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1016/0360-3016(94)00419-L |
P698 | PubMed publication ID | 7713784 |
P2093 | author name string | Myerson RJ | |
Coia LR | |||
Tepper JE | |||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | adaptive radiation therapy | Q180507 |
P304 | page(s) | 1213-1236 | |
P577 | publication date | 1995-03-01 | |
P1433 | published in | International Journal of Radiation Oncology Biology Physics | Q2296252 |
P1476 | title | Late effects of radiation therapy on the gastrointestinal tract | |
P478 | volume | 31 |
Q39125629 | A Bayesian Dose-finding Design for Drug Combination Trials with Delayed Toxicities |
Q82492031 | A mechanism for abnormal angiogenesis in human radiation proctitis: analysis of expression profile for angiogenic factors |
Q37808350 | A patient with tracheoesophageal fistula and esophageal cancer after radiotherapy |
Q81230456 | A phase II study to evaluate WF10 in patients with late hemorrhagic radiation cystitis and proctitis |
Q71987900 | A question-filled future for dose-escalation in prostate cancer—Regarding shipley et al., IJROBP 32:3–12; 1995 |
Q36394782 | A systematic review of the effectiveness of palliative interventions to treat rectal tenesmus in cancer |
Q35171514 | A unique case of a patient with rectal cancer who developed benign esophageal stenosis after localized rectal radiation and systemic chemotherapy |
Q54478240 | Aberrant promoter methylation and reduced expression of p16 gene in esophageal squamous cell carcinoma from Kashmir valley: a high-risk area. |
Q30414737 | Accelerated fraction radiotherapy with capecitabine as neoadjuvant therapy for borderline resectable pancreatic cancer |
Q35571229 | Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer. |
Q36644653 | Adjuvant androgen deprivation impacts late rectal toxicity after conformal radiotherapy of prostate carcinoma |
Q41416682 | Adjuvant radiation therapy for adenocarcinoma of the rectum |
Q43631942 | Adjuvant radiochemotherapy in the treatment of completely resected, locally advanced gastric cancer |
Q74510582 | Age has no impact on acute and late toxicity of curative thoracic radiotherapy |
Q42459427 | Alteration of the enterohepatic recirculation of bile acids in rats after exposure to ionizing radiation |
Q41860214 | An Intractable Caustic Esophageal Stricture Successfully Managed with Sequential Treatment Comprising Incision with an Insulated-Tip Knife, Balloon Dilation, and an Oral Steroid |
Q33187289 | Automated beam angle and weight selection in radiotherapy treatment planning applied to pancreas tumors |
Q30795111 | BAYESIAN DATA AUGMENTATION DOSE FINDING WITH CONTINUAL REASSESSMENT METHOD AND DELAYED TOXICITY. |
Q47234449 | Banding the Sleeve Improves Weight Loss in Midterm Follow-up. |
Q73232500 | Carcinoma of the cervix: analysis of complications after primary external beam radiation and Ir-192 HDR brachytherapy |
Q44859376 | Chemotherapy followed by abdominal cavity irradiation for feline lymphoblastic lymphoma |
Q74213699 | Chronic radiation enteritis: women's food tolerances after radiation treatment for gynecologic cancer |
Q30668524 | Chronic radiation proctitis |
Q36922615 | Clinical risk factors for late intestinal toxicity after radiotherapy: a systematic review protocol |
Q53833299 | Clinicopathological examination of ESD as salvage therapy for esophageal cancer after definitive chemo-radiation therapy. |
Q37030219 | Colostomy is a simple and effective procedure for severe chronic radiation proctitis |
Q41341964 | Comparison of Efficacy of Self-Expandable Metallic Stent Placement in the Unresectable Esophageal Cancer Patients |
Q52038674 | Comparison of methods for calculating rectal dose after (125)I prostate brachytherapy implants. |
Q38014349 | Complications of oncologic therapy in the abdomen and pelvis: a review |
Q35604300 | Conservative therapies for hemorrhagic radiation proctitis: a review |
Q31154842 | Correlation between infectious disease and soil radiation in Japan: an exploratory study using national sentinel surveillance data |
Q42539127 | D-xylose test of resorption as a method to determine radiation side effects in the small intestine |
Q35937087 | Developments in treatment of primary irresectable rectal cancer |
Q74816597 | Dose response in prostate cancer with 8-12 years' follow-up |
Q34277926 | Effects of proton pump inhibitors on lung cancer precise radiotherapy-induced radiation pneumonitis |
Q28213381 | Effects of radiation damage on intestinal morphology |
Q35215796 | Effects of radiation on normal tissue: consequences and mechanisms. |
Q43843853 | Efficacy of argon plasma coagulation in the treatment of radiation-induced hemorrhagic gastroduodenal vascular ectasia |
Q26766042 | Emerging techniques and efficacy of endoscopic esophageal reconstruction and lumen restoration for complete esophageal obstruction |
Q28076526 | Endoscopic and non-endoscopic approaches for the management of radiation-induced rectal bleeding |
Q36526357 | Endoscopic dilation of complete oesophageal obstructions with a combined antegrade-retrograde rendezvous technique |
Q77621145 | Endoscopy in patients receiving radiation therapy to the thorax |
Q92714016 | Esophageal Stricture Following Radiation, Concurrent Immunochemotherapy, Treated With Hyperbaric Oxygen and Dilation |
Q44177718 | Estimating risks of radiotherapy complications as part of informed consent: the high degree of variability between radiation oncologists may be related to experience |
Q97523372 | Evaluation of Roles of MicroRNA-21 and MicroRNA-18a in Esophageal Squamous Cell Carcinoma and Comparison of Their Changes in Expression Post-Chemoradiotherapy |
Q42008170 | Evidence of delayed gastrointestinal syndrome in high-dose irradiated mice |
Q40085481 | Factors That Affect Stent-Related Complications in Patients with Malignant Obstruction of the Esophagus or Gastric Cardia |
Q84860482 | Factors affecting the success of endoscopic bougia dilatation of radiation-induced esophageal stricture |
Q73371698 | Fibrogenic signals in patients with radiation enteritis are associated with increased connective tissue growth factor expression |
Q46042376 | Fluoroscopically guided balloon dilation for benign bronchial stricture occurring after radiotherapy in patients with lung cancer. |
Q33436594 | Functional results after radiochemotherapy and total mesorectal excision for rectal cancer. |
Q34339631 | Gastrectomy for the treatment of refractory gastric ulceration after radioembolization with 90Y microspheres |
Q51049933 | Gastroduodenal injury after radioembolization of hepatic tumors. |
Q37701750 | Gastroduodenal ulceration associated with radioembolization for the treatment of hepatic tumors: an institutional experience and review of the literature |
Q28086904 | Gastrointestinal Toxicities With Combined Antiangiogenic and Stereotactic Body Radiation Therapy |
Q36541173 | Gastrointestinal radiation injury: symptoms, risk factors and mechanisms |
Q73035250 | Gene transfer of human manganese superoxide dismutase protects small intestinal villi from radiation injury |
Q35285282 | Health-related quality of life and late morbidity in concurrent chemoradiation and radiotherapy alone in patients with locally advanced cervical carcinoma |
Q85624349 | Hemorrhagic radiation gastritis successfully treated with repeated intra-arterial steroid infusions |
Q35771996 | How safe is adjuvant chemotherapy and radiotherapy for rectal cancer? |
Q52973472 | Impact on Radiological and Pathological Response with Neoadjuvant Chemoradiation and Its Effect on Survival in Squamous Cell Carcinoma of Thoracic Esophagus. |
Q36674244 | Intensity modulated radiation therapy for retroperitoneal sarcoma: a case for dose escalation and organ at risk toxicity reduction. |
Q47109594 | Interactions between TGF-β1, canonical WNT/β-catenin pathway and PPAR γ in radiation-induced fibrosis |
Q40344727 | Interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma: long-term follow-up |
Q36011154 | Intestinal Obstruction in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. |
Q36822499 | Intestinal failure after surgery for complicated radiation enteritis |
Q52638842 | Keratinocyte growth factor pretreatment prevents radiation-induced intestinal damage in a mouse model. |
Q36819575 | Late adverse effects of radiation therapy for rectal cancer - a systematic overview |
Q87800797 | Late complications after proctectomy in rectal cancer patients who underwent radiotherapy |
Q77525836 | Late effects of intraoperative radiation therapy in anastomotic rat colon |
Q53581860 | Late effects of radiation therapy for prostate carcinoma: the patient's perspective of bladder, bowel and sexual morbidity. |
Q36211601 | Late small bowel toxicity after adjuvant treatment for rectal cancer |
Q37587488 | Local advanced rectal cancer perforation in the midst of preoperative chemoradiotherapy: A case report and literature review |
Q49145881 | Long-term effects in children treated with radiotherapy for head and neck rhabdomyosarcoma |
Q38733090 | Loss of the Wnt receptor frizzled 7 in the mouse gastric epithelium is deleterious and triggers rapid repopulation in vivo |
Q77797545 | Management and long-term complications of pediatric cancer |
Q36811458 | Management of normal tissue toxicity associated with chemoradiation (primary skin, esophagus, and lung). |
Q79363986 | Matrix metalloproteinases in rectal mucosa, tumour and plasma: response after preoperative irradiation |
Q38266659 | Morbidity among long-term survivors after pancreatoduodenectomy for pancreatic adenocarcinoma |
Q42517855 | Morphologic alterations in esophageal squamous cell carcinoma after preoperative high dose rate intraluminal brachytherapy |
Q35687452 | Neoadjuvant treatment in rectal cancer: actual status |
Q28204192 | Non surgical interventions for late radiation proctitis in patients who have received radical radiotherapy to the pelvis |
Q36001497 | Oncological outcome after free jejunal flap reconstruction for carcinoma of the hypopharynx |
Q34552345 | Optimising the treatment of upper gastrointestinal fistulae |
Q60153378 | Optimization of conformal radiation treatment of prostate cancer: Report of a dose escalation study |
Q33903563 | Outcomes of salvage high-dose-rate brachytherapy with or without external beam radiotherapy for isolated vaginal recurrence of endometrial cancer. |
Q41972470 | PPARs in Irradiation-Induced Gastrointestinal Toxicity |
Q37921854 | Pathology of oesophagitis |
Q43353514 | Patient-rating of distressful symptoms after treatment for early cervical cancer |
Q39217503 | Phase II study of chemoselection with docetaxel plus cisplatin and 5-fluorouracil induction chemotherapy and subsequent conversion surgery for locally advanced unresectable oesophageal cancer |
Q28083513 | Photodynamic therapy: one step ahead with self-assembled nanoparticles |
Q80111840 | Postoperative irradiation for rectal cancer increases the risk of small bowel obstruction after surgery |
Q33789531 | Prevention of chronic radiation enteritis |
Q36677699 | Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years? |
Q33517124 | Protective role of R-spondin1, an intestinal stem cell growth factor, against radiation-induced gastrointestinal syndrome in mice |
Q34632048 | Radiation - friend or foe? Presidential address to Ulster Medical Society 4th October 2012 |
Q87412528 | Radiation enteritis |
Q34560451 | Radiation induced small bowel "web" formation is associated with acquired microvascular dysfunction |
Q39448990 | Radiation proctitis: current strategies in management |
Q84146623 | Radiation therapy for gastric wall metastasis from esophageal carcinoma |
Q57117558 | Radiation-induced damage in different segments of the rat intestine after external beam irradiation of the liver |
Q34155843 | Radiation-induced esophageal squamous cell carcinoma in situ |
Q50855599 | Radiation-induced esophageal strictures treated with fluoroscopic balloon dilation: clinical outcomes and factors influencing recurrence in 62 patients. |
Q37643563 | Radiation-induced esophagitis in lung cancer |
Q36070558 | Radiation-induced fibrosis: mechanisms and implications for therapy |
Q47097039 | Radiation-induced rectovaginal fistulas in locally advanced gynaecological malignancies-new patients, old problem? |
Q33598373 | Radiotherapy planning techniques for thyroid cancer |
Q46713101 | Rebampide enema therapy as a treatment for patients with chronic radiation proctitis: initial treatment or when other methods of conservative management have failed |
Q60153379 | Rectal bleeding after conformal 3D treatment of prostate cancer: Time to occurrence, response to treatment and duration of morbidity |
Q42229973 | Reduced dose to small bowel with the prone position and a belly board versus the supine position in neoadjuvant 3D conformal radiotherapy for rectal adenocarcinoma. |
Q36912563 | Rho/ROCK pathway as a molecular target for modulation of intestinal radiation-induced toxicity. |
Q60928090 | Risk factors for fistula formation after interstitial brachytherapy for locally advanced gynecological cancers involving vagina |
Q41545765 | Robust EM Continual Reassessment Method in Oncology Dose Finding |
Q28088346 | SBRT: A viable option for treating adrenal gland metastases |
Q35640632 | Salvage prostatectomy in patients who have failed radiation therapy or cryotherapy as primary treatment for prostate cancer |
Q64910652 | Salvage treatment with high-dose-rate brachytherapy for isolated vaginal endometrial cancer recurrence. |
Q33382863 | Scintigraphic evaluation of oesophageal transit during radiotherapy to the mediastinum |
Q46604493 | Severe intestinal toxicity after stereotactic ablative radiotherapy for abdominopelvic malignancies |
Q38662952 | Simple diagrammatic approach to delineate duodenum on a radiotherapy planning CT scan |
Q53609083 | Stomach-preserving gastric bypass for unresectable pancreatic cancer. |
Q42118900 | Subtotal gastrectomy for diffused hemorrhagic gastritis induced by radiation, following liver resection for hilar cholangiocarcinoma. A case report |
Q43584410 | Successful and sustained treatment of chronic radiation proctitis with antioxidant vitamins E and C. |
Q33212714 | Successful recanalization of a completely obliterated esophageal stricture by using an endoscopic rendezvous maneuver |
Q81692168 | Surgical experience with small bowel damage secondary to pelvic radiotherapy |
Q33276161 | Surgical spacer placement prior carbon ion radiotherapy (CIRT): an effective feasible strategy to improve the treatment for sacral chordoma |
Q73627308 | Surgical treatment of recalcitrant radiation-induced gastric erosions |
Q24608553 | Survivors of childhood cancer have increased risk of gastrointestinal complications later in life |
Q33923024 | The association of rectal equivalent dose in 2 Gy fractions (EQD2) to late rectal toxicity in locally advanced cervical cancer patients who were evaluated by rectosigmoidoscopy in Faculty of Medicine, Chiang Mai University. |
Q57703910 | The effect of rectal heterogeneity on wall dose in high dose rate brachytherapy |
Q91754520 | The effects of N-acetylcysteine on radiotherapy-induced small intestinal damage in rats |
Q38476635 | The efficacy of the combination therapy with oral and topical mesalazine for patients with the first episode of radiation proctitis |
Q34552338 | The relevance of gastrointestinal fistulae in clinical practice: a review |
Q57806095 | The risk factors for benign small bowel obstruction following curative resection in patients with rectal cancer |
Q43934476 | The utility of hyperbaric oxygen therapy to treat recurrent acute bowel obstruction after previous pelvic radiotherapy: a case series |
Q37175958 | Tissue expander placement and adjuvant radiotherapy after surgical resection of retroperitoneal liposarcoma offers improved local control. |
Q33503893 | Transcription factor AP-1 in esophageal squamous cell carcinoma: alterations in activity and expression during human Papillomavirus infection |
Q34121459 | Treating cancer patients. Practical monitoring and management of therapy-related complications. |
Q79396497 | Treatment of a radiation-induced rectal ulcer with hyperbaric oxygen therapy in a man with prostate cancer |
Q53677615 | Treatment of pancreatic cancer tumors with intensity-modulated radiation therapy (IMRT) using the volume at risk approach (VARA): employing dose-volume histogram (DVH) and normal tissue complication probability (NTCP) to evaluate small bowel toxicit |
Q33781707 | Treatment of solitary extramedullary plasmacytoma of the stomach with endoscopic submucosal dissection |
Q87082728 | Upper gastrointestinal complications associated with gemcitabine-concurrent proton radiotherapy for inoperable pancreatic cancer |
Q83138307 | Wide-mouthed sacculation of the esophagus: a cause of dysphagia after radiation therapy |
Q89281916 | [Imaging of side effects after radiation therapy] |
Q73630637 | [Induction chemotherapy followed by concomitant combined radiotherapy and chemotherapy in stage III non-small cell bronchial carcinoma] |
Q74617413 | [Late effects of radiations on the esophagus] |
Q78018831 | [Radiation-induced esophageal carcinoma: report of 11 cases] |
Q73343070 | [Radiotherapy for stage III, inoperable, asymptomatic small cell lung cancer. Final results of a prospective randomized study (240 patients)] |